CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo
Alessandro Antonelli(University of Pisa), Paolo Miccoli(University of Pisa)
Cited by 57
Related Papers
No related papers found
Powered by citation graph analysis